Organization Overview
Alternative names
irinotecan (Camptosar) (2015)
Adenocarcinoma (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Colorectal Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 1)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Head and Neck Neoplasms (Phase 1)
Lung Neoplasms (Phase 2)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 3)
Psoriasis (Phase 2)
Sarcoma (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Uveitis (Phase 2)